S. Tummala

Quantifying Gastric Helicobacter pylori Infection: A Comparison of Quantitative Culture, Urease Breath Testing, and Histology

M. Osburne, C. Kelly, S. Mullin, 2007, Digestive Diseases and Sciences.

Helicobacter pylori Infection Stimulates Plasminogen Activator Inhibitor 1 Production by Gastric Epithelial Cells

K. Becker, R. Peek, S. Sheth, 2008, Infection and Immunity.

A prospective study of risk factors and historical trends in metronidazole failure for Clostridium difficile infection.

M. Hu, C. Kelly, L. Kyne, 2008, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Open-label, dose escalation phase I study in healthy volunteers to evaluate the safety and pharmacokinetics of a human monoclonal antibody to Clostridium difficile toxin A.

I. Lowy, A. Lembo, L. Davidson, 2008, Vaccine.

Update on the immunologic basis of Helicobacter pylori gastritis

C. Kelly, S. Keates, S. Tummala, 2004, Current opinion in gastroenterology.

Association between IgG2 and IgG3 subclass responses to toxin A and recurrent Clostridium difficile-associated disease.

J. Sheikh, C. Kelly, Xinhua Chen, 2007, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

Prospective derivation and validation of a clinical prediction rule for recurrent Clostridium difficile infection.

M. Hu, D. Leffler, C. Kelly, 2009, Gastroenterology.

rospective Derivation and Validation of a Clinical Prediction Rule for ecurrent Clostridium difficile Infection

D. Leffler, C. Kelly, L. Kyne, 2022 .